As red tape grows, pharma research flees India
Editorial Comment | Business Standard | New Delhi | 8 September 2014 Piramal Enterprises, the Piramal group’s flagship company operating primarily in the healthcare sector, has decided to close its Mumbai drug research and development (R&D) unit, its largest in… Continue reading